Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer.

Annals of surgery

Volumn 256, Issue 5, 2012, Pages

  Nitsche, Ulrich ^a   Rosenberg, Robert ^b   Balmert, Alexander ^b   Schuster, Tibor ^b   Slotta Huspenina, Julia ^b   Herrmann, Pia ^b   Bader, Franz G ^b   Friess, Helmut ^b   Schlag, Peter M ^b   Stein, Ulrike ^b   Janssen, Klaus Peter ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; MACC1 PROTEIN, HUMAN; ONCOPROTEIN; OSTEOPONTIN; RAS PROTEIN; SASH1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CODON; COLON TUMOR; EXON; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METASTASIS; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION; PATHOLOGY; PREDICTIVE VALUE; RISK ASSESSMENT; STATISTICAL ANALYSIS; SURVIVAL RATE; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CODON; COLONIC NEOPLASMS; DATA INTERPRETATION, STATISTICAL; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OSTEOPONTIN; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; RISK ASSESSMENT; SURVIVAL RATE; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84872025444     PISSN: None     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/sla.0b013e318272de87     Document Type: Article

References (0)